Neogen (NEOG) Piper Sandler 36th Annual Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Piper Sandler 36th Annual Healthcare Conference summary
8 Jul, 2026Financial Performance and Growth
Preliminary Q2 revenue reached approximately $230 million, with sequential improvement in core growth rates and a return to positive growth in animal safety after an 8% decline in Q1.
Margin improvement initiatives are underway, expected to take effect in Q3 and Q4, with primary benefits anticipated in H2 and further details to be shared during the January earnings call.
Market share recovery is ongoing, with gains observed in both Q1 and Q2, following operational challenges that previously resulted in a $30 million headwind.
Guidance for fiscal 2025 targets 2% reported growth at the midpoint, with FX fluctuations noted as a key variable.
The company aims to be cash flow positive this fiscal year, targeting a debt to EBITDA ratio below three to enable renewed acquisition activity, and expects strong free cash flow generation as integration spending winds down.
Strategic Initiatives and Integration
Integration of the 3M food safety business is nearly complete, with three of four manufacturing lines relocated and the final Petrifilm line expected to be fully operational within two years.
Expansion into 16 new countries has been achieved, supported by over 900 customer-facing representatives and regional teams in LATAM, Asia Pacific, and Europe.
Distribution challenges in animal safety were largely isolated to specific customers and have since improved, with positive sales trends emerging.
No further ERP changes are planned for the remainder of the year, allowing focus on operational stability.
Post-integration targets include MSD-HSD annual core revenue growth, 30%+ adjusted EBITDA margin, and net leverage below 2.0x.
Market Environment and Industry Trends
The macro environment remains challenging, with prolonged unit declines among customers due to inflation, though the rate of decline is narrowing and core growth remains positive.
Food safety demand is resilient and less sensitive to political shifts, as regulatory and consumer focus on safe food persists regardless of administration.
Industry growth in food safety is estimated at mid-single digits in the current environment, with potential to return to high single digits as conditions normalize.
Key growth drivers include rising food allergies, higher food standards, demand for organic products, and increased traceability requirements.
Serves large, growing markets: $22B food safety (6-8% LT growth) and $55B animal safety (4-6% LT growth).
Latest events from Neogen
- Integration progress and international growth position the business for margin expansion and recovery.NEOG
2024 Wells Fargo Healthcare Conference9 Jul 2026 - Q2 FY26 delivered 2.9% core growth, margin expansion, and a raised FY26 outlook.NEOG
Q2 20269 Jul 2026 - Q3 revenue fell 4.4% year-over-year, but Food Safety grew and FY26 guidance was raised.NEOG
Q3 20268 Jul 2026 - Q4 revenue fell 2.1% as integration neared completion; FY25 targets core growth and margin gains.NEOG
Q4 20242 Feb 2026 - Integration nears completion as innovation and global expansion drive strong growth prospects.NEOG
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q1 revenue and margins fell, but guidance and integration priorities remain intact.NEOG
Q1 202519 Jan 2026 - Raised FY2026 outlook and turnaround strategy drive confidence in growth and innovation.NEOG
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - Goodwill impairment drives $456M net loss despite core growth and margin actions.NEOG
Q2 202510 Jan 2026 - Integration progress and innovation drive growth amid regulatory momentum and portfolio actions.NEOG
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026